Show simple item record

Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience

dc.contributor.authorBasaran, Mert
dc.contributor.authorTuncer, Samuray
dc.contributor.authorDogan, Oner
dc.contributor.authorBuyukbabani, Nesimi
dc.contributor.authorTanyildiz, Burak
dc.date.accessioned2021-03-04T18:43:08Z
dc.date.available2021-03-04T18:43:08Z
dc.date.issued2015
dc.identifier.citationTuncer S., Tanyildiz B., Basaran M., Buyukbabani N., Dogan O., "Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience", CURRENT EYE RESEARCH, cilt.40, ss.780-785, 2015
dc.identifier.issn0271-3683
dc.identifier.otherav_8c2f6ba3-dfe2-4426-9bad-b8948f9b1c3c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/94855
dc.identifier.urihttps://doi.org/10.3109/02713683.2014.959605
dc.description.abstractPurpose: To evaluate the efficacy of systemic rituximab immunotherapy in the management of primary ocular adnexal lymphomas (OAL).
dc.language.isoeng
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titleSystemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience
dc.typeMakale
dc.relation.journalCURRENT EYE RESEARCH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume40
dc.identifier.issue8
dc.identifier.startpage780
dc.identifier.endpage785
dc.contributor.firstauthorID70382


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record